Symoxir fibrinogen protein decomposition assay reagent - Taiwan Registration f5838b817ad90b73c7996225378d991a
Access comprehensive regulatory information for Symoxir fibrinogen protein decomposition assay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f5838b817ad90b73c7996225378d991a and manufactured by BIOKIT S.A.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
ACL TOP family series instruments quantitatively determine the concentration of fibrinogen protein decomposition in human citrate acidified plasma.
B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
A.1660 Quality control materials (analytical and non-analytical); A.1150 calibration;; B.7320 Analysis of pro-fiber/fiber-based protein disintegration products
import
Dates and Status
Jan 08, 2018
Jan 08, 2028